{"symbol": "CLLS", "companyName": "Cellectis S.A.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.cellectis.com", "description": "Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.", "CEO": "Andre Choulika", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}